Home » Archive

News

News, Syndication, Xconomy »

Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data

Posted by sandiegobiotech May 29th, 2012 .
No Comments

Vertex Pharmaceuticals saw its stock rocket on news earlier this month that its two-drug combo treatment for cystic fibrosis showed a strong benefit in a clinical trial, but the stock is coming back…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

Safety Analyses Lead Sangart to Move Ahead with ‘Oxygen Therapeutic’

Posted by sandiegobiotech May 28th, 2012 .
No Comments

Encouraging results in a second mid-stage trial of an oxygen-carrying compound has prompted San Diego’s Sangart to draw on an additional $50 million from Leucadia National (NYSE: LUK), a diversified…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Xconomist of the Week: Evan Snyder—Stem Cell Reality Check

Posted by sandiegobiotech May 25th, 2012 .
No Comments

San Diego Xconomist Evan Snyder has been called a “stem cell revolutionary” and is regarded as a father in the field of stem cell research. When we talked in his office at San Diego’s Sanford-Burnham…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Xconomist of the Week: Evan Snyder—Stem Cell Reality Check

Posted by sandiegobiotech May 25th, 2012 .
No Comments

San Diego Xconomist Evan Snyder has been called a “stem cell revolutionary” and is regarded as a father in the field of stem cell research. When we talked in his office at San Diego’s Sanford-Burnham…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

Posted by Mary Canady May 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 25, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) (the “Company” and “La Jolla”) held its 2012 Annual Meeting of Stockholders on May 22. All matters submitted to a vote of the stockholders …

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

Posted by Mary Canady May 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 25, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) (the “Company” and “La Jolla”) held its 2012 Annual Meeting of Stockholders on May 22. All matters submitted to a vote of the stockholders …

More...

News, Syndication, Xconomy »

Nokia Joins X Prize in $2.25M Wireless Health “Sensing Challenge”

Posted by sandiegobiotech May 24th, 2012 .
No Comments

When the X Prize Foundation’s Peter Diamandis took the stage in San Diego this morning at the Wireless-Life Sciences Alliance (WLSA) annual convergence summit, he said it was the perfect audience for…

[[Click headline to continue reading.]]

More...

Marketwire, News, Syndication »

Nokia Sensing X CHALLENGE — Searching the World for the Most Powerful Digital Health Sensors to Transform the Healthcare Industry

Posted by Mary Canady May 24th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 24, 2012) – The X PRIZE Foundation and Nokia today announced the launch of the Nokia Sensing X CHALLENGE, a $2.25 million global competition to stimulate the development of a new generation of health sensors and sens…

More...

Marketwire, News, Syndication »

True Diagnostics Receives CE Mark for TrueDX(TM) Platform & TSH Test

Posted by Mary Canady May 24th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 24, 2012) – True Diagnostics, Inc.T (www.TrueDiagnostics.com) has announced it has received a CE Mark to allow it to distribute its TrueDX Platform and quantitative TSH (Thyroid Stimulating Hormone) test in Europe. W…

More...

Drug Development, News, Syndication, Xconomy »

SD Life Sciences Roundup: Takeda Consolidates, Startups Raise Cash

Posted by sandiegobiotech May 24th, 2012 .
No Comments

It’s been a busy week for startup funding, with Obalon Therapeutics, Aperio Technologies, Topera, and Ivera Medical closing on financing deals. We’ve also got drug development news from Ocera…

[[Click headline to continue reading.]]

More...